Answers are grounded in this paper and cite their sources.
The preliminary findings from our pilot study demonstrate that 4% citrate is effective in maintaining catheter patency and does not appear to have any increased incidence of infections. Because citrate is significantly cheaper and has a more favorable side effect profile than heparin, it can be considered a potentially better locking agent in HD catheters.
No takes yet. Share an insight, caveat, or question.
MacRae et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: